COVID-19 Daily Epidemiology Update: Key Updates

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 29

COVID-19 daily epidemiology update

Updated: February 4, 2022, 9 am EST

Summary of COVID-19 cases across Canada and over time. Contains detailed data about the spread of the
virus over time and in different regions of the country. Includes breakdowns by age and sex or gender.
Provides an overview of hospitalizations and deaths, testing, variants of concern and exposures.

Key updates as of February 4, 2022, 9 am EST

Cases today Total cases Active cases Total resolved Deaths today Total deaths

14,217 3,096,217 180,492 2,881,344 169 34,381

Total tests performed Daily percent positive (last 7 days) Daily tests per 100,000 population (last 7 days)

56,795,249 17.5% 207

We update these sections Monday to Friday at 9:00 AM EST: Key updates, Current situation and National
overview. Laboratory data represents specimens received by labs up to February 1, 2022 to allow time to
process results.
We update these sections every Friday: COVID-19 variants in Canada, Epidemic curve, Demographics,
How people were exposed, and Severe illness and outcomes.
The Cases following vaccination section is updated every Tuesday
Of the 13 jurisdictions reporting updates, no new cases were reported in 0 provinces and territories in the
past 24 hours.
Of the 13 jurisdictions reporting updates, no new deaths were reported in 2 provinces and territories in the
past 24 hours.
Due to changes in COVID-19 testing policies in many jurisdictions starting in late December 2021, case
counts will under estimate the total burden of disease.
Resulting from the delays in data entry caused by the recent high number of cases, Nova Scotia issued a
press release on December 10 indicating that they would begin announcing the daily number of new
cases using laboratory test results, not data from Panorama (their public health disease information
system) on the Nova Scotia COVID-19 Dashboard. These reporting changes are expected to be
temporary. In the absence of Panorama data, we will report Nova Scotia’s cumulative cases up until
December 9 and add the daily lab positive cases reported. We will use the estimated number of active
cases from Nova Scotia’s updates to calculate the number of recoveries as of December 10. Once Nova
Scotia resumes reporting case data from Panorama, our data will be retroactively corrected.
Current situation
Figure 1a. Count
of
cases (last 7 days)
of COVID-19, by
province/territory as of February 3, 2022
(Last data update February 4, 2022, 9 am EST)

Canada 97,888 Count of cases (last 7 days) of


COVID-19

10,000 and higher


5,000 to 9,999
500 to 4,999
50 to 499
25 to 49
1 to 24
130 0

917
404
on First Nations
N/A
reserves
10,237

16,947 1,491
4,041

22,509
6,752 27,824
1,506

2,874

2,256

The count of cases (last 7 days) of COVID-19 in Canada was 97,888 as of February 3, 2022.

a. This information is based on data our provincial and territorial partners published on cases, deaths, and
testing daily, and are current as of the day they are published. Today’s numbers are current as of February
3, 2022. For the most up to date data for any province, territory or city, please visit their website. The
number of cases or deaths reported on previous days may differ slightly from those on the provincial and
territorial websites as these websites may update historic case and death counts as new information
becomes available.
b. Due to changes in COVID-19 testing policies in many jurisdictions starting in late December 2021, case
counts will under estimate the total burden of disease.

c. Resulting from the delays in data entry caused by the recent high number of cases, Nova Scotia issued a
press release on December 10 indicating that they would begin announcing the daily number of new
cases using laboratory test results, not data from Panorama (their public health disease information
system) on the Nova Scotia COVID-19 Dashboard. These reporting changes are expected to be
temporary. In the absence of Panorama data, we will report Nova Scotia’s cumulative cases up until
December 9 and add the daily lab positive cases reported. We will use the estimated number of active
cases from Nova Scotia’s updates to calculate the number of recoveries as of December 10. Once Nova
Scotia resumes reporting case data from Panorama, our data will be retroactively corrected.
Areas in Canada with cases of COVID-19 as of February 3, 2022

Moving Moving
average tests average
Cases last 7 Deaths last 7 Total tests performed last positivity
Total cases days Active cases Resolved Deaths days performed 7 days last 7 days

Location Count Rate* Count Rate* Count Rate* Count Count Rate* Count Rate* Count Count Rate* Percent

British Columbia 329,143 6,312 10,237 196 26,830 515 299,657 2,656 51 68 1.3 5,458,187 9,547 183 20.5%

Alberta 501,347 11,284 16,947 381 33,879 763 463,860 3,608 81 90 2.0 6,739,970 7,115 160 35.4%

Saskatchewan 120,745 10,234 6,752 572 10,271 871 109,473 1,001 85 16 1.4 1,441,846 3,033 257 37.0%

Manitoba 122,012 8,817 4,041 292 16,787 1,213 103,642 1,583 114 45 3.3 1,427,314 1,797 130 30.8%

Ontario 1,043,923 7,041 27,824 188 39,656 267 992,616 11,651 79 421 2.8 22,512,593 25,460 172 14.2%

Quebec 872,029 10,135 22,509 262 39,877 463 818,774 13,378 155 313 3.6 15,916,920 25,652 298 11.7%

Newfoundland 17,984 3,455 1,491 286 1,731 333 16,208 45 9 7 1.3 547,192 1,590 305 16.6%
and Labrador

New Brunswick 29,905 3,789 2,256 286 4,014 509 25,640 251 32 27 3.4 699,397 1,526 193 20.9%

Nova Scotia 39,129 3,944 2,874 290 3,647 368 35,325 157 16 15 1.5 1,715,821 3,040 307 13.6%

Prince Edward 8,565 5,212 1,506 917 2,282 1,389 6,272 11 7 2 1.2 255,323 81 49 12.0%
Island

Yukon 3,168 7,370 130 302 109 254 3,041 18 42 2 4.7 9,129 N/A N/A N/A

Northwest 6,363 13,983 917 2,015 967 2,125 5,379 17 37 2 4.4 39,782 31 69 26.0%
Territories

Nunavut 1,891 4,799 404 1,025 442 1,122 1,444 5 13 0 0.0 31,699 200 508 25.3%

Canada 3,096,217 8,096 97,888 256 180,492 472 2,881,344 34,381 90 1,008 2.6 56,795,249 79,072 207 17.5%

* Rate per 100,000 population


Moving average of cases (last 7 days) Moving average of cases (last 7 days) Moving average of cases (last 7 days)

0
5k
10k
15k
20k
25k
30k
35k
40k
0
5k
10k
15k
20k
25k
30k
35k
40k
0
5k
10k
15k
20k
25k
30k
35k
40k
01 01 01
Ap Ap Ap
r' r' r'
20 20 20
01 01 01
Ju Ju Ju
l '2 l '2 l '2
01 0 01 0 01 0
O O O
ct ct ct
'2 '2 '2
01 0 01 0 01 0
Ja Ja Ja
n n n
'2 '2 '2
01 1 01 1 01 1
Ap Ap Ap
r' r' r'
21 21 21
Canada

Quebec
01 01 01
Ju Ju Ju

Reporting date
Reporting date
Reporting date
l '2 l '2 l '2

Saskatchewan
01 1 01 1 01 1
O O O
ct ct ct
'2 '2 '2
01 1 01 1 01 1
Ja Ja Ja
n n n
'2 '2 '2
2 2 2
Figure 1b. Moving average

Moving average of cases (last 7 days) Moving average of cases (last 7 days) Moving average of cases (last 7 days)

0
5k
10k
15k
20k
25k
30k
35k
40k
0
5k
10k
15k
20k
25k
30k
35k
40k
0
5k
10k
15k
20k
25k
30k
35k
40k

01 01 01
Ap Ap Ap
r' r' r'
20 20 20
01 01 01
Ju Ju Ju
l '2 l '2 l '2
01 0 01 0 01 0
O O O
ct ct ct
'2 '2 '2
01 0 01 0 01 0
Ja Ja Ja
n n n
'2 '2 '2
01 1 01 1 01 1
Ap Ap Ap
r' r' r'
21 21 21
01 01 01
Ju Ju Manitoba Ju

Reporting date
Reporting date
Reporting date

l '2 l '2 l '2


1 1 1
British Columbia

01 01 01
O O O
ct ct ct
'2 '2 '2
01 1 01 1 01 1
Ja Ja Ja
n n n

Newfoundland and Labrador


'2 '2 '2
2 2 2

of
cases (last 7 days)

Moving average of cases (last 7 days) Moving average of cases (last 7 days) Moving average of cases (last 7 days)

0
5k
10k
15k
20k
25k
30k
35k
40k
0
5k
10k
15k
20k
25k
30k
35k
40k
0
5k
10k
15k
20k
25k
30k
35k
40k

01 01 01
Ap Ap Ap
r' r' r'
20 20 20
01 01 01
Ju Ju Ju
l '2 l '2 l '2
01 0 01 0 01 0
O O O
COVID-19 in Canada as of February 3, 2022
(Last data update February 4, 2022, 9 am EST)

ct ct ct
'2 '2 '2
01 0 01 0 01 0
Ja Ja Ja
n n n
'2 '2 '2
01 1 01 1 01 1
Ap Ap Ap
r' r' r'
Alberta

21 21 21
Ontario

01 01 01
Ju Ju Ju

Reporting date
Reporting date
Reporting date

l '2 l '2 l '2


1 1 1
01
O
New Brunswick 01
O
01
O
ct ct ct
'2 '2 '2
same for each figure. This allows you to compare the provinces and territories on the same timescale.

01 1 01 1 01 1
Ja Ja Ja
n n n
'2 '2 '2
 The figures below show cases over time. The range of dates (January 31st, 2020 - present date) is the

2 2 2

of
Moving average of cases (last 7 days) Nova Scotia Prince Edward Island Yukon

Moving average of cases (last 7 days)

Moving average of cases (last 7 days)


40k 40k 40k

35k 35k 35k

30k 30k 30k

25k 25k 25k

20k 20k 20k

15k 15k 15k

10k 10k 10k

5k 5k 5k

0 0 0
1

2
0

1
20

21

20

21

20

21
0

1
'2

'2

'2

'2

'2

'2
'2

'2

'2

'2

'2

'2
l '2

l '2

l '2

l '2

l '2

l '2
r'

r'

r'

r'

r'

r'
n

n
ct

ct

ct

ct

ct

ct
Ap

Ju

Ap

Ju

Ap

Ju

Ap

Ju

Ap

Ju

Ap

Ju
Ja

Ja

Ja

Ja

Ja

Ja
O

O
01

01

01

01

01

01
01

01

01

01

01

01
01

01

01

01

01

01
01

01

01

01

01

01
Reporting date Reporting date Reporting date

Northwest Territories Nunavut


Moving average of cases (last 7 days)

Moving average of cases (last 7 days)

40k 40k

35k 35k

30k 30k

25k 25k

20k 20k

15k 15k

10k 10k

5k 5k

0 0
1

2
0

1
20

21

20

21
0

1
'2

'2

'2

'2
'2

'2

'2

'2
l '2

l '2

l '2

l '2
r'

r'

r'

r'
n

n
ct

ct

ct

ct
Ap

Ju

Ap

Ju

Ap

Ju

Ap

Ju
Ja

Ja

Ja

Ja
O

O
01

01

01

01
01

01

01

01
01

01

01

01
01

01

01

01

Reporting date Reporting date

a. Due to changes in COVID-19 testing policies in many jurisdictions starting in late December 2021, case
counts will under estimate the total burden of disease.
b. This information is based on data from our provincial and territorial partners. Data about cases was last
updated on February 3, 2022. Laboratory data includes specimens received by labs up to February 1,
2022. For the most up to date data for any province, territory or city, please visit their web site.
c. The 7-day moving average is the total of the daily numbers for the previous 7 days (up to and including
the day of the last update), divided by the number of days for which data is available. We go back and
update the moving averages as provinces and territories submit more data. We calculate the national 7-
day moving average by summing the 7-day moving average from the provinces and territories then
dividing by the national population if a rate is calculated.
d. Resulting from the delays in data entry caused by the recent high number of cases, Nova Scotia issued a
press release on December 10 indicating that they would begin announcing the daily number of new
cases using laboratory test results, not data from Panorama (their public health disease information
system) on the Nova Scotia COVID-19 Dashboard. These reporting changes are expected to be
temporary. In the absence of Panorama data, we will report Nova Scotia’s cumulative cases up until
December 9 and add the daily lab positive cases reported. We will use the estimated number of active
cases from Nova Scotia’s updates to calculate the number of recoveries as of December 10. Once Nova
Scotia resumes reporting case data from Panorama, our data will be retroactively corrected.
Downloadable data (in .csv format).

Due to changes in COVID-19 testing policies in many jurisdictions starting in late December 2021, case
counts will under estimate the total burden of disease.

Note: Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.
National overview
There have been over 56,795,249 COVID-19 tests performed in Canada or 1,484,994 tests per 1 million
people. For information about testing trends, please see the Detailed weekly epidemiological report (PDF).

Table 1. Daily* change in the number of cases, deaths and tests performed, by province or
territory, as of February 3, 2022
(Last data update February 4, 2022, 9 am EST)

Location New cases New deaths Tests performed

British Columbia 1,518 13 10,097

Alberta 2,370 15 7,338

Saskatchewan 851 4 2,236

Manitoba 357 7 1,758

Ontario 4,098 75 27,720

Quebec 3,592 42 28,923

Newfoundland and Labrador 198 1 1,480

New Brunswick 411 4 1,755

Nova Scotia 401 4 3,121

Prince Edward Island 186 0 78

Yukon 22 2 N/A

Northwest Territories 142 2 50

Nunavut 71 0 172

Canada 14,217 169 84,728

*
The new cases, deaths and tests reflect the difference between a province or territory's current report and
their last report. Some provinces and territories do not update daily.

N/A means that no daily update was provided by the province or territory.

Due to changes in COVID-19 testing policies in many jurisdictions starting in late December 2021, case counts
will under estimate the total burden of disease.

Resulting from the delays in data entry caused by the recent high number of cases, Nova Scotia issued a
press release on December 10 indicating that they would begin announcing the daily number of new cases
using laboratory test results, not data from Panorama (their public health disease information system) on the
Nova Scotia COVID-19 Dashboard. These reporting changes are expected to be temporary. In the absence of
Panorama data, we will report Nova Scotia’s cumulative cases up until December 9 and add the daily lab
positive cases reported. We will use the estimated number of active cases from Nova Scotia’s updates to
calculate the number of recoveries as of December 10. Once Nova Scotia resumes reporting case data from
Panorama, our data will be retroactively corrected.
COVID-19 variants in Canada
All viruses, including COVID-19, change over time. These changes are called mutations, and result in variants
of the virus. Not all mutations are of concern. Most do not cause more severe illness. However, some
mutations result in variants of concern or variants of interest.

A variant of concern has mutations that are significant to public health. Before a variant of interest is
considered one of concern, scientists and public health professionals must determine if the mutations result in
an actual change in the behaviour of the virus. For example, it might:

spread more easily


cause more severe illness
require different treatments, or
reduce vaccine effectiveness

There are several variants of interest that have mutations similar to variants of concern, but we don’t yet know
if they pose a higher risk to public health.

The Public Health Agency of Canada (PHAC) works with provincial and territorial partners and the Canadian
COVID-19 Genomics Network (CanCOGeN) to sequence a percentage of all positive COVID-19 test results.
Sequencing reveals the genetic code of the virus, which tells us which variant is involved in a specific case of
COVID-19. We report the proportion of COVID-19 variants in Canada every week.

We collect evidence to determine if new variants meet the definition for a variant of concern or a variant of
interest. Many variants are being tracked across Canada and around the world. Variants of concern now
represent a majority of COVID-19 cases in Canada.

Current variants of concern in Canada include:

Alpha (B.1.1.7)
Beta (B.1.351)
Gamma (P.1)
Delta (B.1.617.2)
Omicron (B.1.1.529)

New variants will continue to appear. We must remain vigilant and take all available measures to limit spread.
Figure 2. Weekly variant breakdown Updated: February 4, 2022, 4 pm EDT
 The graphic shows the percentage mix of COVID-19 variants detected in Canada through whole genome
sequencing, by week of sample collection. You can see the numbers for each date by hovering over, tabbing
to, or long-pressing any of the bars. To see a specific variant or variant grouping, click or press return. Repeat
to restore the complete graph. Sublineages or offshoots for some variants can be revealed or hidden by
clicking on the name of the variant in the legend.
Accumulating data
Variants of concern
Alpha
100%
Delta
AY.103
AY.25
Percentage of samples sequenced

80%
AY.25.1
AY.27
AY.74
60%
Other Delta
Omicron

40% Other variants


Other

20%

0%
1

2
02

02

02

02

02

02

02

02

02

02
,2

,2

,2

,2

,2

,2

,2

,2

,2

,2
14

21

28

05

12

19

26

02

09

16
ov

ov

ov

ec

ec

ec

ec

n
Ja

Ja

Ja
N

Week of sample collection

This information is based on whole genome sequencing from surveillance testing in all provinces and territories. In addition to
sequencing done by the National Microbiology Laboratory in Winnipeg, data is included from provincial and territorial
laboratories.

Sequencing takes from 1 to 3 weeks to complete, so the proportions for recent weeks may change as more data are added.
Surveillance in each province or territory is organized and prioritized according to local needs and may change from time to
time. Because of differences in local sampling and reporting, the percentages illustrate trends rather than precise
measurements.
Weekly variant breakdown
Percentage of COVID-19 cases identified through whole genome sequencing, presented by variant and
by week of sample collection.

Nov 14, Nov 21, Nov 28, Dec 05, Dec 12, Dec 19, Dec 26, Jan 02, Jan 09, Jan 1
Variant 2021 2021 2021 2021 2021 2021 2021 2022 2022 2022
Grouping (n=5,363) (n=6,226) (n=6,571) (n=6,399) (n=7,756) (n=8,777) (n=8,918) (n=7,906) (n=4,836) (n=1,

Variants 99.9% 99.9% 100.1% 100.0% 99.8% 99.9% 100.1% 99.8% 99.8% 100.
of
concern

Alpha 0.0% - - - - - - - - -

B.1.1.7 0.0% - - - - - - - - -

Delta 99.9% 99.7% 98.0% 77.4% 42.2% 15.1% 5.8% 3.8% 3.0% 1.8%

AY.103 12.1% 15.1% 13.5% 10.1% 5.2% 1.7% 0.5% 0.3% 0.3% -

AY.25 5.8% 6.8% 7.7% 5.5% 1.7% 0.2% 0.2% 0.1% 0.0% -

AY.25.1 49.2% 44.6% 43.6% 36.8% 23.2% 9.0% 3.3% 2.4% 2.0% 1.0%

AY.27 10.7% 8.2% 5.8% 2.9% 1.6% 1.0% 0.3% 0.2% 0.1% 0.2%

AY.74 3.0% 4.7% 4.0% 3.1% 1.0% 0.1% 0.1% 0.0% 0.0% -

Other 19.1% 20.3% 23.4% 19.0% 9.5% 3.1% 1.4% 0.8% 0.6% 0.6%
Delta

Omicron - 0.2% 2.1% 22.6% 57.6% 84.8% 94.3% 96.0% 96.8% 98.2

B.1.1.529 - - - - - - - - 0.0% 0.2%

BA.1 - 0.1% 1.3% 15.8% 46.3% 59.5% 63.3% 75.9% 75.0% 62.0%

BA.1.1 - 0.1% 0.7% 6.8% 11.3% 25.3% 30.6% 18.8% 20.0% 29.6%

BA.2 - - 0.1% - - 0.0% 0.4% 1.3% 1.8% 6.4%

Other 0.0% - 0.0% 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.1%
variants

Other 0.0% - 0.0% 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.1%

Note: The shaded columns on the right represent a period of accumulating data.

Contributing laboratories:
Saskatchewan - Roy Romanow Provincial Laboratory (RRPL)
Public Health Ontario (PHO)
Newfoundland and Labrador - Eastern Health
New Brunswick – Vitalité Health Network
Manitoba Cadham Provincial Laboratory
Laboratoire de santé publique du Québec (LSPQ)
BCCDC Public Health Laboratory
Alberta Precision Labs - Edmonton (APL)
National Microbiology Laboratory (NML) - supplemental sequencing for all provinces and territories

Detailed case information


The tables and figures below reflect detailed case information provided to the Public Health Agency of Canada
(PHAC) by health authorities in the provinces and territories. This data is updated every week. It may change
as we get more information about cases.

Updated: February 4, 2022, 8 am EST

Epidemic curve
As of February 4, 2022, 8 am EST, PHAC has received detailed case report data on 3,011,786 cases. Both
exposure and symptom onset date were available for 1,946,095 (64.6%) cases 1.

The shaded area on the far right of Figure 3 represents a period of accumulating data. This is the period of
time (1 to 2 weeks) before the latest cases are reported to PHAC. This delay is a result of the time required to
seek health care, get tested and receive results. It also takes time for public health authorities to gather
information on cases. We update this information as it becomes available.
Number of reported cases
15
-J

0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
50,000
02 an-
-F 20
e
23 b-2
-F 0
e
15 b-2
-M 0
a
05 r-2
-A 0
p
26 r-2
-A 0
EST (total cases)

17 pr-2
-M 0
a
07 y-2
-J 0
u
28 n-2
-J 0
un
19 -20
-J
09 ul-2
-A 0
u
30 g-2
-A 0
u
20 g-2
-S 0
e
11 p-2
-O 0
01 ct-2
-N 0
o
22 v-2
-N 0
o
13 v-2
-D 0
e
03 c-2
-J 0
an
24 -2
-J 1
a
14 n-2
-F 1
eb

Date
07 -2
-M 1
28 ar-2
-M 1
a
18 r-2
-A 1
09 pr-2
-M 1
30 ay-2
-M 1
a
20 y-2
-J 1
un
11 -21
-J
01 ul-2
-A 1
u
22 g-2
-A 1
u
12 g-2
-S 1
e
03 p-2
-O 1
c
24 t-2
-O 1
14 ct-2
-N 1
o
05 v-2
-D 1
e
26 c-2
-D 1
e
16 c-2
-J 1
an
-2
2
Figure 3. COVID-19 cases (n=3,011,786 1) in Canada by date 2 as of February 4, 2022, 8 am
Number of reported cases Number of reported cases
15 15
-J -J

0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
50,000
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
22,000
24,000
26,000
28,000
02 an- 02 an-
-F 20 -F 20
e e
23 b-2 23 b-2
-F 0 -F 0
e e
15 b-2 15 b-2
-M 0 -M 0

80+

0-11
a a

12-19
20-29
30-39
40-49
50-59
60-69
70-79
05 r-2 05 r-2
-A 0 -A 0
p p
26 r-2 26 r-2
-A 0 -A 0
17 pr-2 17 pr-2
-M 0 -M 0
EST (by exposure)

a a
07 y-2 07 y-2
-J 0 -J 0
Information pending

u u
Domestic - Unknown

28 n-2 28 n-2
-J 0 -J 0
un un
19 -20 19 -20
Travelled outside of Canada

-J -J
09 ul-2 09 ul-2
-A 0 -A 0
u u
Domestic - Contact with a traveller

EST (by age - 10 year groups)


30 g-2 30 g-2
-A 0 -A 0
u u
Domestic - Contact with a COVID case

20 g-2 20 g-2
-S 0 -S 0
e e
11 p-2 11 p-2
-O 0 -O 0
01 ct-2 01 ct-2
-N 0 -N 0
o o
22 v-2 22 v-2
-N 0 -N 0
o o
13 v-2 13 v-2
-D 0 -D 0
e e
03 c-2 03 c-2
-J 0 -J 0
an an
24 -2 24 -2
-J 1 -J 1
a a
14 n-2 14 n-2
-F 1 -F 1
eb eb

Date
Date
07 -2 07 -2
-M 1 -M 1
28 ar-2 28 ar-2
-M 1 -M 1
a a
18 r-2 18 r-2
-A 1 -A 1
09 pr-2 09 pr-2
-M 1 -M 1
30 ay-2 30 ay-2
-M 1 -M 1
a a
20 y-2 20 y-2
-J 1 -J 1
un un
11 -21 11 -21
-J -J
01 ul-2 01 ul-2
-A 1 -A 1
u u
22 g-2 22 g-2
-A 1 -A 1
u u
12 g-2 12 g-2
-S 1 -S 1
e e
03 p-2 03 p-2
-O 1 -O 1
c c
24 t-2 24 t-2
-O 1 -O 1
14 ct-2 14 ct-2
-N 1 -N 1
o o
05 v-2 05 v-2
-D 1 -D 1
e e
26 c-2 26 c-2
-D 1 -D 1
e e
16 c-2 16 c-2
-J 1 -J 1
an an
-2 -2
2 2
Figure 3. COVID-19 cases (n=3,010,668 1) in Canada by date 2 as of February 4, 2022, 8 am
Figure 3. COVID-19 cases (n=1,946,095 1) in Canada by date 2 as of February 4, 2022, 8 am
Figure 3. COVID-19 cases (n=3,010,668 1) in Canada by date 2 as of February 4, 2022, 8 am
EST (by age - 20 year groups)

80+
60-79
50,000 40-59
20-39
45,000 0-19
Number of reported cases

40,000

35,000

30,000

25,000

20,000

15,000

10,000

5,000

0
-F 20

-F 0

-M 0

-A 0

-A 0
-M 0

-J 0

-J 0
19 -20

-A 0

-A 0

-S 0

-O 0
-N 0

-N 0

-D 0

-J 0

-J 1

-F 1

-M 1

-M 1

-A 1
-M 1

-M 1

-J 1
11 -21

-A 1

-A 1

-S 1

-O 1

-O 1
-N 1

-D 1

-D 1

-J 1

2
23 b-2

15 b-2

05 r-2

26 r-2
17 pr-2

07 y-2

28 n-2

09 ul-2

30 g-2

20 g-2

11 p-2
01 ct-2

22 v-2

13 v-2

03 c-2

24 -2

14 n-2

07 -2

28 ar-2

18 r-2
09 pr-2

30 ay-2

20 y-2

01 ul-2

22 g-2

12 g-2

03 p-2

24 t-2
14 ct-2

05 v-2

26 c-2

16 c-2

-2
02 an-

un

an

eb

un

an
c
a

a
a

e
e

e
-J

-J
-J
15

Date

This figure may underestimate the total number of cases among returning travelers. Exposure history is not available for all
cases and jurisdictions have not all consistently reported exposure history to PHAC throughout the pandemic.
Demographics
We have detailed case report data from 3,011,786 cases. We know the age of patients in 99.96% of cases,
and both age and gender in 99.73% of cases.

Of the cases reported in Canada so far, 52.1% were female and 36.9% were between 20 and 39 years old
(Figure 4).

Figure 4.
Age
distribution of COVID-19 cases (n=3,010,668 1) in Canada as of
February 4, 2022, 8 am EST
4

0-11 337,513 (11.2%)

12-19 275,425 (9.1%)

20-29 586,614 (19.5%)


Age group (years)

30-39 525,404 (17.5%)

40-49 451,773 (15.0%)

50-59 370,039 (12.3%)

60-69 221,707 (7.4%)

70-79 113,663 (3.8%)

80+ 128,530 (4.3%)

0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 550,000 600,000 650,000
Number (Proportion (%))

Male Female Other


0-11 175,595 (52.1%) 161,305 (47.9%) 19 (0.0%)

12-19 134,834 (49.1%) 139,920 (50.9%) 13 (0.0%)

20-29 277,154 (47.4%) 307,387 (52.6%) 34 (0.0%)


Age group (years)

30-39 244,714 (46.7%) 279,366 (53.3%) 30 (0.0%)

40-49 208,133 (46.2%) 242,647 (53.8%) 18 (0.0%)

50-59 178,655 (48.4%) 190,635 (51.6%) 16 (0.0%)

60-69 113,278 (51.2%) 107,981 (48.8%) 9 (0.0%)

70-79 57,164 (50.4%)56,299 (49.6%) 2 (0.0%)

80+ 47,821 (37.3%) 80,488 (62.7%) 0 (0.0%)

0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 550,000 600,000 650,000
Number (Proportion (%))
Age by gender 4 distribution of COVID-19 cases (n=3,010,668 1) in Canada, February 4,
2022, 8 am EST

Age Number of cases with Number of male Number of other


group case reports cases Number of female cases
(years) (percentage) (percentage) cases (percentage) (percentage)

0-11 337,513 (11.2%) 175,595 (12.2%) 161,305 (10.3%) 19 (13.5%)

12-19 275,425 (9.1%) 134,834 (9.4%) 139,920 (8.9%) 13 (9.2%)

20-29 586,614 (19.5%) 277,154 (19.3%) 307,387 (19.6%) 34 (24.1%)

30-39 525,404 (17.5%) 244,714 (17.0%) 279,366 (17.8%) 30 (21.3%)

40-49 451,773 (15.0%) 208,133 (14.5%) 242,647 (15.5%) 18 (12.8%)

50-59 370,039 (12.3%) 178,655 (12.4%) 190,635 (12.2%) 16 (11.3%)

60-69 221,707 (7.4%) 113,278 (7.9%) 107,981 (6.9%) 9 (6.4%)

70-79 113,663 (3.8%) 57,164 (4.0%) 56,299 (3.6%) 2 (1.4%)

80+ 128,530 (4.3%) 47,821 (3.3%) 80,488 (5.1%) 0 (0.0%)

Total 3,010,668 (100%) 1,437,348 (100%) 1,566,028 (100%) 141 (100%)

How people were exposed 3

In Canada , detailed case report data were provided for 3,011,786 cases. We have
exposure history for 1,946,095 (64.6%) cases. The probable exposure setting of these cases 1 are:

any exposure that occurred in Canada: 1,483,283 (76.2%), including


from contact with a known COVID case: 804,048 (41.3%)
from contact with a traveller: 9,965 (0.5%)
from an unknown source: 669,270 (34.4%)
currently unknown (information pending): 446,436 (22.9%)
travelled outside of Canada: 16,376 (0.8%)
Cases following vaccination
Data extracted on January 28, 2022 for cases from December 14, 2020 up until January 15, 2022.

While the COVID-19 vaccines are highly effective, a percentage of the population who are vaccinated may
become infected with COVID-19 if they are exposed to the virus that causes it. This means that even with high
vaccine effectiveness, a percentage of people who are vaccinated against COVID-19 will still get sick and
some may be hospitalized or die.

It is also possible that a person could be infected just before or just after vaccination and still get sick. It
typically takes about two weeks for the body to build protection after vaccination, so a person could get sick if
the vaccine has not had enough time to provide protection.

Cases reported since the start of the vaccination campaign, as of January 15, 2022
Since the start of the vaccination campaign on December 14, 2020, PHAC received case-level vaccine history
data for 72.7% (n=1,458,433) of COVID-19 cases aged 12 years or older.

Of these cases:

771,095 (52.9%) were unvaccinated at the time of their episode date


44,494 (3.1%) were not yet protected by the vaccine, as their episode date occurred less than 14 days
after their first dose
61,209 (4.2%) were only partially vaccinated, as their episode date occurred either 14 days or more after
their first dose or less than 14 days after their second dose
581,635 (39.9%) were fully vaccinated, as their episode date occurred 14 days or more after their second
dose

Figure 5. Distribution of confirmed COVID-19 cases reported to PHAC by vaccination


status as of January 15, 2022
Cases Hospitalizations Deaths
100% 100% 100%
90% 90% 90%
Percentage of cases

Percentage of cases

Percentage of cases

80% 80% 80%


71.7% 70.3%
70% 70% 70%
60% 60% 60%
52.9%
50% 50% 50%
40% 39.9% 40% 40%
30% 30% 30%
20% 20% 17.1% 20% 16.8%
10% 10% 5.1% 6.1% 10% 6.4% 6.5%
3.1% 4.2%
0% 0% 0%
d d d d d d d d d d d d
ate cte ate ate ate cte ate ate ate cte ate ate
ccin rote ccin ccin ccin rote ccin ccin ccin rote ccin ccin
va tp va va va tp va va va tp va va
Un ye lly lly Un ye lly lly Un ye lly lly
not r tia Fu not r tia Fu not r tia Fu
s Pa s Pa s Pa
se se se
Ca Ca Ca
Vaccination status Vaccination status Vaccination status
Characteristics and severe outcomes associated unvaccinated, partially vaccinated and
fully vaccinated confirmed cases reported to PHAC, as of January 15, 2022

Status Cases Hospitalizations Deaths

Unvaccinated 52.9% 71.7% 70.3%

Cases not yet protected 3.1% 5.1% 6.4%

Partially vaccinated 4.2% 6.1% 6.5%

Fully vaccinated 39.9% 17.1% 16.8%

Among the twelve jurisdictions that have reported case-level vaccine history data to PHAC, a total of 24.6
million people have received at least one dose of the COVID-19 vaccine as of January 15, 2022.

Of these people:

24.3 million achieved partial vaccination status, of which 61,209 (0.25%) were diagnosed with COVID-19
while partially vaccinated
22.6 million achieved full vaccination status, of which 581,635 (2.57%) were diagnosed with COVID-19
while fully vaccinated

Based on detailed case information reported to PHAC from provinces and territories, cases following
vaccination were reported more frequently among females (Table 2). This may be the result of higher
vaccination coverage in Canada among females due to the prioritization healthcare workers as part of the
vaccine rollout.

Table 2. Characteristics and severe outcomes associated unvaccinated, partially vaccinated


and fully vaccinated confirmed cases reported to PHAC, as of January 15, 2022

Cases not yet Partially Fully


Unvaccinated protected vaccinated vaccinated Total cases
(n=771,095) (n=44,494) (n=61,209) (n=581,635) (n=1,458,433)

Male 393,016 21,480 (3.1%) 28,999 (4.1%) 257,738 701,233


(56.0%) (36.8%) (100%)
Gender*
Female 375,396 22,955 (3.0%) 32,102 (4.3%) 322,264 752,717
(49.9%) (42.8%) (100%)

Hospitalizations 43,540 3,118 (5.1%) 3,717 (6.1%) 10,387 60,762


(71.7%) (17.1%) (100%)

Deaths 8,479 (70.3%) 770 (6.4%) 788 (6.5%) 2,032 (16.8%) 12,069
(100%)
Source: Detailed case information received by PHAC from provinces and territories, since December 14, 2020
Note:
Twelve of thirteen provinces and territories have reported case-level vaccine history data to PHAC as part of the
national COVID-19 dataset. Ten provinces and territories have reported complete case-level vaccine history data to
PHAC since October 2021. A data cut-off of January 15, 2022 was used to account for routine reporting delays
associated with vaccine history information.
*Cases with missing gender were excluded. Where available, gender data was used; when gender data was
unavailable, sex data was used. Reliable data on gender diverse respondents are unavailable due to small counts.

Fully vaccinated individuals diagnosed with COVID-19 were significantly protected from severe outcomes.
Compared to unvaccinated cases, fully vaccinated cases were 74% less likely to be hospitalized and 80% less
likely to die as a result of their illness (Table 3).

Table 3. Risk of severe outcomes among fully vaccinated cases compared to


unvaccinated cases as of January 15, 2022

Severe Outcome Adjusted* Odds Ratio (95% CI)

Hospitalizations 0.26 (0.25 - 0.26)

Deaths 0.20 (0.19 - 0.21)

*Adjusted for 10-year age groups and month of episode date


Source: Detailed case information received by PHAC from provinces and territories
Note: Due to the nature of the dataset (i.e. confirmed cases of COVID-19 in Canada), the odds of severe outcomes
among cases following vaccination only considers vaccinated individuals that contracted COVID-19. It does not
reflect the protection conferred by the vaccines to prevent COVID-19 infection.

Data for this analysis is extracted from the COVID-19 national data set, which contains detailed case-level
information received by PHAC from all provinces and territories. Note that a data cut-off of January 15,
2022 was used to account for any reporting delays associated with vaccine history information. There are
currently twelve jurisdictions reporting case-level vaccine history data to PHAC as part of the national
COVID-19 dataset.

PHAC monitors cases following vaccination using the following categories:

Unvaccinated cases: include those who were unvaccinated at the time of their episode date.
Cases not yet protected from vaccination include those whose episode date occurred less than 14 days after their
first dose of the vaccine.
Partially vaccinated cases include those whose episode date occurred 14 days or more after their first vaccine dose
or less than 14 days after their second dose of the vaccine.
Fully vaccinated cases include those whose episode date occurred 14 days or more after their second dose of a
two dose vaccine series or those whose episode date occurred 14 days or more after one dose of a one-dose
vaccine.

Note: When symptom onset date is unavailable or the case is asymptomatic, episode date uses the
following dates as a proxy for classification: laboratory specimen collection date, or laboratory testing
date.

For more information on cases following vaccination, please see the Weekly epidemiology report (PDF)
available on the Government of Canada’s COVID-19 data trends page.

Severe illness and outcomes


Hospital use

Figure 6. Daily number of hospital beds and ICU beds occupied by COVID-19 patients
as of January
31, 2022
Total patients hospitalized
11,000
10,000
9,000
8,000
7,000
Number

6,000
5,000
4,000
3,000
2,000
1,000
0
il

21

il

22
be

be
r

r
l

l
Ju

Ju
Ap

Ap
20

20
o

o
ct

ct
O

Patients in non-ICU Patients in ICU Patients mechanically vented


11,000 11,000 11,000
10,000 10,000 10,000
9,000 9,000 9,000
8,000 8,000 8,000
7,000 7,000 7,000
6,000 6,000 6,000
5,000 5,000 5,000
4,000 4,000 4,000
3,000 3,000 3,000
2,000 2,000 2,000
1,000 1,000 1,000
0 0 0
ril

ly

er

21

ril

ly

er

22

ril

ly

er

21

ril

ly

er

22

ril

ly

er

21

ril

ly

er

22
Ju

Ju

Ju

Ju

Ju

Ju
Ap

Ap

Ap

Ap

Ap

Ap
ob

ob

ob

ob

ob

ob
20

20

20

20

20

20
ct

ct

ct

ct

ct

ct
O

Between January 24, 2022 and January 31, 2022:


the total number of hospital beds occupied by COVID-19 patients decreased from 11,022 to 9,943 beds.
the number of non-ICU beds occupied by COVID-19 patients decreased from 9,789 to 8,800 beds.
the number of ICU beds occupied by COVID-19 patients decreased from 1,233 to 1,143 beds.
the number of COVID-19 patients who were mechanically vented decreased from 638 to 595.

Hospitalizations and deaths to date


We have detailed case report data on 3,011,786 cases, and hospitalization status for 3,007,529 (99.9%) of
them:

122,292 cases (4.1%) were hospitalized, of whom:


21,590 (17.7%) were admitted to the ICU
2,532 (2.1%) needed mechanical ventilation

The provinces and territories provided detailed case report forms for 33,792 deaths related to COVID-19.

Figure 7a. Age and gender 4 distribution of COVID-19 cases hospitalized in Canada as of
February 4, 2022, 8 am EST (n=122,074 1)
Male Female Other
0-11 n = 2,245 (1.8%)

12-19 n = 1,272 (1.0%)

20-29 n = 5,800 (4.8%)


Age group (years)

30-39 n = 9,199 (7.5%)

40-49 n = 10,792 (8.8%)

50-59 n = 16,604 (13.6%)

60-69 n = 21,167 (17.3%)

70-79 n = 23,708 (19.4%)

80+ n = 31,287 (25.6%)

0 5,000 10,000 15,000 20,000 25,000 30,000 35,000


Number (Proportion (%))

Figure 7b. Age and gender 4 distribution of COVID-19 cases admitted to ICU in Canada as of
February 4, 2022, 8 am EST (n=21,560 1)
Male Female Other
0-11 n = 220 (1.0%)

12-19 n = 151 (0.7%)

20-29 n = 657 (3.0%)


Age group (years)

30-39 n = 1,370 (6.4%)

40-49 n = 2,267 (10.5%)

50-59 n = 4,237 (19.7%)

60-69 n = 5,643 (26.2%)

70-79 n = 4,831 (22.4%)

80+ n = 2,184 (10.1%)

0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000
Number (Proportion (%))

Figure 7c. Age and gender 4 distribution of COVID-19 cases deceased in Canada as of
February 4, 2022, 8 am EST (n=33,717 1)
Male Female Other
0-11 n = 19 (0.1%)

12-19 n = 10 (0.0%)

20-29 n = 99 (0.3%)
Age group (years)

30-39 n = 243 (0.7%)

40-49 n = 549 (1.6%)

50-59 n = 1,507 (4.5%)

60-69 n = 3,570 (10.6%)

70-79 n = 7,136 (21.2%)

80+ n = 20,584 (61.0%)

0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 22,000
Number (Proportion (%))

Data note: Figure 7 includes COVID-19 cases hospitalized, admitted to ICU, and deceased for which age and
gender information were available. Therefore, some COVID-19 hospitalizations, ICU admissions, and deaths
may not be included in Figure 7.
Age and gender 4 distribution of COVID-19 cases hospitalized in Canada as of February 4,
2022, 8 am EST (n=122,074 1)

Age Number of cases with Number of male Number of other


group case reports cases Number of female cases
(years) (percentage) (percentage) cases (percentage) (percentage)

0-11 2,245 (1.8%) 1,250 (1.0%) 994 (0.8%) 1 (0.0%)

12-19 1,272 (1.0%) 571 (0.5%) 701 (0.6%) 0 (0.0%)

20-29 5,800 (4.8%) 2,260 (1.9%) 3,539 (2.9%) 1 (0.0%)

30-39 9,199 (7.5%) 4,012 (3.3%) 5,187 (4.2%) 0 (0.0%)

40-49 10,792 (8.8%) 6,204 (5.1%) 4,588 (3.8%) 0 (0.0%)

50-59 16,604 (13.6%) 9,970 (8.2%) 6,634 (5.4%) 0 (0.0%)

60-69 21,167 (17.3%) 12,482 (10.2%) 8,685 (7.1%) 0 (0.0%)

70-79 23,708 (19.4%) 13,360 (10.9%) 10,348 (8.5%) 0 (0.0%)

80+ 31,287 (25.6%) 14,937 (12.2%) 16,350 (13.4%) 0 (0.0%)

Age and gender 4 distribution of COVID-19 cases admitted to ICU in Canada as of


February 4, 2022, 8 am EST (n=21,560 1)

Age Number of cases with Number of male Number of other


group case reports cases Number of female cases
(years) (percentage) (percentage) cases (percentage) (percentage)

0-11 220 (1.0%) 119 (0.6%) 101 (0.5%) 0 (0.0%)

12-19 151 (0.7%) 84 (0.4%) 67 (0.3%) 0 (0.0%)

20-29 657 (3.0%) 353 (1.6%) 304 (1.4%) 0 (0.0%)

30-39 1,370 (6.4%) 792 (3.7%) 578 (2.7%) 0 (0.0%)

40-49 2,267 (10.5%) 1,403 (6.5%) 864 (4.0%) 0 (0.0%)

50-59 4,237 (19.7%) 2,784 (12.9%) 1,453 (6.7%) 0 (0.0%)

60-69 5,643 (26.2%) 3,620 (16.8%) 2,023 (9.4%) 0 (0.0%)

70-79 4,831 (22.4%) 3,064 (14.2%) 1,767 (8.2%) 0 (0.0%)

80+ 2,184 (10.1%) 1,275 (5.9%) 909 (4.2%) 0 (0.0%)


Age and gender 4 distribution of COVID-19 cases deceased in Canada as of February 4,
2022, 8 am EST (n=33,717 1)

Age Number of cases with Number of male Number of other


group case reports cases Number of female cases
(years) (percentage) (percentage) cases (percentage) (percentage)

0-11 19 (0.1%) 6 (0.0%) 13 (0.0%) 0 (0.0%)

12-19 10 (0.0%) 6 (0.0%) 4 (0.0%) 0 (0.0%)

20-29 99 (0.3%) 61 (0.2%) 38 (0.1%) 0 (0.0%)

30-39 243 (0.7%) 151 (0.4%) 92 (0.3%) 0 (0.0%)

40-49 549 (1.6%) 348 (1.0%) 201 (0.6%) 0 (0.0%)

50-59 1,507 (4.5%) 930 (2.8%) 577 (1.7%) 0 (0.0%)

60-69 3,570 (10.6%) 2,282 (6.8%) 1,288 (3.8%) 0 (0.0%)

70-79 7,136 (21.2%) 4,294 (12.7%) 2,842 (8.4%) 0 (0.0%)

80+ 20,584 (61.0%) 9,455 (28.0%) 11,129 (33.0%) 0 (0.00%)


Provincial, territorial and international reporting
For more information, please refer to provincial or territorial COVID-19 webpages:

British Columbia
Alberta
Saskatchewan
Manitoba
Ontario
Quebec
Newfoundland and Labrador
New Brunswick
Nova Scotia
Prince Edward Island
Yukon
Northwest Territories
Nunavut
World Health Organization
Centers for Disease Control and Prevention
European Centre for Disease Control and Prevention

1 This figure is based on cases for which a case report form was received by the Public Health
Agency of Canada from provincial or territorial partners.

2 The shaded area represents a period of accumulating data where it is expected that cases have
occurred but have not yet been reported nationally. The earliest of the following dates were used as
an estimate: Onset date, Specimen Collection Date, Laboratory Testing Date, Date Reported to
Province or Territory, or Date Reported to PHAC.

3 Exposure information may not be available for all cases. Some jurisdictions haven’t consistently
reported to PHAC how people were exposed throughout the pandemic. As a result, this may
underestimate the total number of cases by different exposures, especially among returning
travelers.

4 Where available, gender data was used; when gender data was unavailable, sex data was used.
Reliable data on gender diverse respondents are unavailable due to small counts.

Date modified:
2022-02-04

You might also like